Centene (CNC) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
8 Jul, 2026Executive summary
2025 adjusted diluted EPS was $2.08, while GAAP diluted loss per share was $(13.53) due to a $6.7 billion goodwill impairment and a $513 million Magellan Health impairment; Q4 adjusted diluted loss per share was $1.19, slightly ahead of expectations.
Total revenues for 2025 increased 20% year-over-year to $194.8 billion, driven by growth in PDP and Marketplace businesses and Medicaid rate increases.
Medicaid profitability improved in the back half of 2025, with Marketplace and Medicare segments performing in line or better than expectations; Medicaid and Medicare Advantage membership declined, while Marketplace and Medicare PDP membership grew.
Strong SG&A management led to a full-year adjusted SG&A expense ratio of 7.4%, down from 8.5% in 2024.
Positioned for meaningful margin improvement and adjusted EPS growth in 2026, targeting over $3 in adjusted EPS, a 40%+ year-over-year increase.
Financial highlights
2025 premium and service revenue reached $174.6 billion, with Q4 revenues up 23% year-over-year.
Q4 GAAP diluted loss per share was $2.24, including a $389 million net loss from the Magellan business divestiture.
Health benefits ratio (HBR) increased to 91.9% for 2025 from 88.3% in 2024, reflecting higher medical costs and program changes.
Cash flow from operations was $5.1 billion for the year, up from $154 million in 2024.
Ended 2025 with $400 million in available cash and a debt-to-capital ratio of 46.5%.
Outlook and guidance
2026 adjusted diluted EPS is projected to exceed $3.00, with GAAP diluted EPS above $1.98.
2026 revenue guidance is $186.5–$190.5 billion, with premium and service revenue projected at $170–$174 billion.
HBR for 2026 is expected between 90.9% and 91.7%; adjusted SG&A expense ratio forecasted at 7.1%–7.7%.
Medicaid member months projected down 5–6% in 2026; Marketplace revenue expected to decline by $8 billion due to policy changes, with membership stabilizing at 3.5 million.
Medicare segment premium revenue to grow by $7.5 billion, mainly from PDP business and yield increases.
Latest events from Centene
- Q2 2026 EPS hit $2.51 on $53.6B revenue, margins improved, and guidance was raised.CNC
Q2 202628 Jul 2026 - Q2 2025 saw higher revenues but a net loss from medical costs and Marketplace risk adjustment shortfall.CNC
Q2 20259 Jul 2026 - 2025 EPS guidance exceeds $7.25, with premium/service revenue at $154–$156B and growth in Duals and ICHRA.CNC
Investor Day 20248 Jul 2026 - 2024 EPS rose 7% to $7.17; 2025 revenue guidance increased by $4B to $158–$160B.CNC
Q4 20248 Jul 2026 - Q1 2025 adjusted EPS up 28% to $2.90, revenue up 17% to $46.6B, guidance raised.CNC
Q1 20251 Jul 2026 - Q1 2026 EPS and revenues exceeded expectations, with improved leverage and strong segment results.CNC
Q1 202628 Apr 2026 - Operational disruption in 2025 drives strategic refocus, governance refresh, and margin recovery plans.CNC
Proxy filing26 Mar 2026 - Key votes include director elections, executive pay, auditor ratification, and board chair proposal.CNC
Proxy filing26 Mar 2026 - 2026 EPS guidance reaffirmed; core businesses on track, with focus on fraud prevention and risk adjustment.CNC
Barclays 28th Annual Global Healthcare Conference10 Mar 2026